deferiprone has been researched along with butylated hydroxytoluene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bebbington, D; Benwell, K; Gaur, S; Harvey, V; Malcolm, CS; Monck, NJ; Palmer, AM; Porter, RH | 1 |
| Bebbington, D; Dawson, CE; Gaur, S; Spencer, J | 1 |
2 other study(ies) available for deferiprone and butylated hydroxytoluene
| Article | Year |
|---|---|
3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1H)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity.
Topics: Animals; Antioxidants; Brain; Drug Evaluation, Preclinical; Free Radical Scavengers; In Vitro Techniques; Iodoacetates; Lipid Peroxidation; Neuroprotective Agents; Oxidative Stress; Pyridones; Rats; Structure-Activity Relationship | 2000 |
Prodrug and covalent linker strategies for the solubilization of dual-action antioxidants/iron chelators.
Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Cross-Linking Reagents; Deferiprone; Hydrolysis; Iron Chelating Agents; Plasma; Polyethylene Glycols; Prodrugs; Pyridones; Rats; Solubility; Structure-Activity Relationship | 2002 |